| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SSTI | Common Stock | Award | $0 | +36.3K | +54.54% | $0.00 | 103K | Feb 28, 2025 | Direct | F1 |
| transaction | SSTI | Common Stock | Sale | -$23.8K | -1.48K | -1.44% | $16.10 | 101K | Mar 3, 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | 1/12 of the shares subject to the award vest on the first Quarterly Date (as defined below) that occurs following the vesting commencement date (February 28, 2025), and 1/12 of the total number of shares subject to the award vest on each Quarterly Date thereafter, subject to the recipient's Continuous Service (as defined in the Issuer's 2017 Equity Incentive Plan, as amended) through each applicable Quarterly Date. "Quarterly Date" means each of February 28, May 31, August 31, and November 30, of a given calendar year. |
| F2 | The Reporting Person sold only the number of shares of common stock necessary to cover applicable tax withholding obligations realized upon the vesting of restricted stock units, as well as any related brokerage commission fees. |
| F3 | The price reported is a weighted average price. The shares were sold at prices ranging from $15.93 to $16.14. The Reporting Person will provide on request to the SEC, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
Title: MD TechnoLogic, EVP Investigative Solutions